Active pharmaceutical ingredients, or APIs, are what make a drug a drug - they produce the desired effect. The process of formulation converts APIs into drug products that patients can use. Most marketed pharmaceutical drugs are manufactured in solid forms such as tablets, capsules, and powders. Now the long-standing, well standardized practice of formulation is facing new challenges. Some advanced APIs are not compatible with standard approaches to formulation due to issues with stability, solubility, or other physicochemical characteristics. In this whitepaper, you will learn about innovative new approaches to solid dosage formulation and how partnering with a contract development and manufacturing organization, or CDMO, that specializes in these techniques will benefit your drug development pipeline.